Cromos Pharma sets a new record in site initiation timelines in Poland
In the beginning of August 2019, Cromos Pharma has initiated a first site in Poland in a trial that had received a regulatory approval just a couple of weeks earlier! Given the typical timelines in this country, this is a record setting result.
This accomplishment is the product of our team’s very hard and coordinated work and, possibly, of the improving regulatory landscape. Poland, while being a champion in patient recruitment, to date hasn’t won any prizes in the regulatory timelines department due to its rather complex site contracting procedures. We are optimistic that the times they are a-changin!
Please stay tuned…